The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Park, Robin | - |
dc.contributor.author | Madhavaram, Shreya | - |
dc.contributor.author | Ji, Jong Dae | - |
dc.date.accessioned | 2021-08-30T12:52:57Z | - |
dc.date.available | 2021-08-30T12:52:57Z | - |
dc.date.created | 2021-06-19 | - |
dc.date.issued | 2020-10 | - |
dc.identifier.issn | 2073-4409 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/52585 | - |
dc.description.abstract | Aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that plays a crucial role in bone remodeling through altering the interplay between bone-forming osteoblasts and bone-resorbing osteoclasts. While effects of AhR signaling in osteoblasts are well understood, the role and mechanism of AhR signaling in regulating osteoclastogenesis is not widely understood. AhR, when binding with exogenous ligands (environmental pollutants such as polycylic aryl hydrocarbon (PAH), dioxins) or endogenous ligand indoxyl-sulfate (IS), has dual functions that are mediated by the nature of the binding ligand, binding time, and specific pathways of distinct ligands. In this review, AhR is discussed with a focus on (i) the role of AhR in osteoclast differentiation and function and (ii) the mechanisms of AhR signaling in inhibiting or promoting osteoclastogenesis. These findings facilitate an understanding of the role of AhR in the functional regulation of osteoclasts and in osteoclast-induced bone destructive conditions such as rheumatoid arthritis and cancer. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | MDPI | - |
dc.subject | T-CELLS | - |
dc.subject | ARYLHYDROCARBON RECEPTOR | - |
dc.subject | BONE-RESORPTION | - |
dc.subject | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN | - |
dc.subject | OSTEOBLASTS | - |
dc.subject | ACTIVATION | - |
dc.subject | TCDD | - |
dc.subject | LIGAND | - |
dc.subject | 3-METHYLCHOLANTHRENE | - |
dc.subject | INHIBITION | - |
dc.title | The Role of Aryl-Hydrocarbon Receptor (AhR) in Osteoclast Differentiation and Function | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Ji, Jong Dae | - |
dc.identifier.doi | 10.3390/cells9102294 | - |
dc.identifier.scopusid | 2-s2.0-85093706111 | - |
dc.identifier.wosid | 000584157200001 | - |
dc.identifier.bibliographicCitation | CELLS, v.9, no.10 | - |
dc.relation.isPartOf | CELLS | - |
dc.citation.title | CELLS | - |
dc.citation.volume | 9 | - |
dc.citation.number | 10 | - |
dc.type.rims | ART | - |
dc.type.docType | Review | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cell Biology | - |
dc.relation.journalWebOfScienceCategory | Cell Biology | - |
dc.subject.keywordPlus | T-CELLS | - |
dc.subject.keywordPlus | ARYLHYDROCARBON RECEPTOR | - |
dc.subject.keywordPlus | BONE-RESORPTION | - |
dc.subject.keywordPlus | 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN | - |
dc.subject.keywordPlus | OSTEOBLASTS | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | TCDD | - |
dc.subject.keywordPlus | LIGAND | - |
dc.subject.keywordPlus | 3-METHYLCHOLANTHRENE | - |
dc.subject.keywordPlus | INHIBITION | - |
dc.subject.keywordAuthor | aryl-hydrocarbon receptor | - |
dc.subject.keywordAuthor | osteoclastogenesis | - |
dc.subject.keywordAuthor | bone remodeling | - |
dc.subject.keywordAuthor | cytochrome P450 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.